Literature DB >> 15504648

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

M Lambert1, P Conus, P Eide, R Mass, A Karow, S Moritz, D Golks, D Naber.   

Abstract

OBJECTIVE: (1) determine which antipsychotic side effects (SE) schizophrenic patients consider the most distressing during treatment with typical antipsychotics, (2) measure the impact of actual and past SE on patients' attitude toward antipsychotics and (3) assess the influence of both on adherence.
METHODS: The 213 schizophrenics, treated with conventional antipsychotics, were recruited in two psychiatric hospitals in Hamburg. Subjects were assessed about type and severity of present and past side effects and their attitude and adherence to antipsychotic treatment.
RESULTS: The 82 (39%) patients presented present SE while 131 (61%) did not. Sexual dysfunctions (P < 0.001), extrapyramidal (P < 0.05) and psychic side effects (P < 0.05) were rated as significantly subjectively more distressing than sedation or vegetative side effects. Patients presenting with present SE compared with patients without present SE had a significantly more negative general attitude toward antipsychotics (P < 0.05), were more doubtful about their efficacy (P < 0.01) and were less likely to encourage a relative to take such a medication in case of need (P < 0.001). A regression analysis indicated that nonadherence was mainly influenced by negative general and efficacy attitudes toward antipsychotics and the experience of past or present antipsychotic side effects.
CONCLUSIONS: All antipsychotic side effects, present or past, can have a durable negative impact on patient's attitude toward antipsychotic treatment and adherence. Non-adherence is mainly determined, among other factors, by these negative attitudes, which are partly influenced by the experience of past or present antipsychotic-induced side effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504648     DOI: 10.1016/j.eurpsy.2004.06.031

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  55 in total

Review 1.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

2.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

3.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

4.  Therapeutic Applications of BCI Technologies.

Authors:  Dennis J McFarland; Janis Daly; Chadwick Boulay; Muhammad Parvaz
Journal:  Brain Comput Interfaces (Abingdon)       Date:  2017-04-10

5.  Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand.

Authors:  Sirijit Suttajit; Sutrak Pilakanta
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

6.  Antipsychotic-induced sexual dysfunction and its management.

Authors:  Yeon Won Park; Yooseok Kim; Jun Ho Lee
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

Review 7.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Authors:  Martin Lambert; Dieter Naber
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Management of patients presenting with acute psychotic episodes of schizophrenia.

Authors:  Pierre Thomas; Köksal Alptekin; Mihai Gheorghe; Mauro Mauri; José Manuel Olivares; Michael Riedel
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Authors:  Rune A Kroken; Erik Johnsen; Torleif Ruud; Tore Wentzel-Larsen; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2009-05-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.